Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Kommoss

Showing results (111-120 of 125) with videos related to

Pageof 13
Sort By:
Nature Communications|March 25, 2023
Genomic characterization of DICER1-associated neoplasms uncovers molecular classesFelix K F Kommoss, Anne-Sophie Chong, Anne-Laure Chong, et al.
Journal of Cancer Research and Clinical Oncology|November 27, 2019
DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnosticsFelix K F Kommoss, Damian Stichel, Daniel Schrimpf, et al.
British Journal of Cancer|January 7, 2015
Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT studyF Trillsch, S Mahner, E Vettorazzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2014
Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT studyF Trillsch, S Mahner, L Woelber, et al.
Geburtshilfe Und Frauenheilkunde|April 29, 2014
S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours: Short version 1.0 - AWMF registration number: 032/035OL, June 2013U Wagner, P Harter, F Hilpert, et al.
Nature Communications|June 16, 2025
Somatic gene delivery faithfully recapitulates a molecular spectrum of high-risk sarcomasRoland Imle, Daniel Blösel, Felix K F Kommoss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2020
Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian CarcinomaPauline Krämer, Aline Talhouk, Mary Anne Brett, et al.
JAMA Network Open|February 2, 2026
Serous Ovarian Cancer Following Opportunistic Bilateral SalpingectomyRamlogan Sowamber, Alice J Mei, Paramdeep Kaur, et al.
Gynecologic Oncology|May 6, 2026
Lymph node involvement, surgery and adjuvant treatment in primary Endometrioid Ovarian carcinoma PAtients with eaRly-stage Disease (LEOPARD) - a multinational team initiativeMarcel Grube, Bianca Ribeiro de Souza, Andrea Neilson, et al.
British Journal of Cancer|November 3, 2022
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium StudyAshley Weir, Eun-Young Kang, Nicola S Meagher, et al.
Pageof 13

Showing results (111-120 of 125) with videos related to

Sort By:
Pageof 13
Nature Communications|March 25, 2023
Genomic characterization of DICER1-associated neoplasms uncovers molecular classesFelix K F Kommoss, Anne-Sophie Chong, Anne-Laure Chong, et al.
Journal of Cancer Research and Clinical Oncology|November 27, 2019
DNA methylation-based profiling of uterine neoplasms: a novel tool to improve gynecologic cancer diagnosticsFelix K F Kommoss, Damian Stichel, Daniel Schrimpf, et al.
British Journal of Cancer|January 7, 2015
Surgical staging and prognosis in serous borderline ovarian tumours (BOT): a subanalysis of the AGO ROBOT studyF Trillsch, S Mahner, E Vettorazzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2014
Age-dependent differences in borderline ovarian tumours (BOT) regarding clinical characteristics and outcome: results from a sub-analysis of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) ROBOT studyF Trillsch, S Mahner, L Woelber, et al.
Geburtshilfe Und Frauenheilkunde|April 29, 2014
S3-Guideline on Diagnostics, Therapy and Follow-up of Malignant Ovarian Tumours: Short version 1.0 - AWMF registration number: 032/035OL, June 2013U Wagner, P Harter, F Hilpert, et al.
Nature Communications|June 16, 2025
Somatic gene delivery faithfully recapitulates a molecular spectrum of high-risk sarcomasRoland Imle, Daniel Blösel, Felix K F Kommoss, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2020
Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian CarcinomaPauline Krämer, Aline Talhouk, Mary Anne Brett, et al.
JAMA Network Open|February 2, 2026
Serous Ovarian Cancer Following Opportunistic Bilateral SalpingectomyRamlogan Sowamber, Alice J Mei, Paramdeep Kaur, et al.
Gynecologic Oncology|May 6, 2026
Lymph node involvement, surgery and adjuvant treatment in primary Endometrioid Ovarian carcinoma PAtients with eaRly-stage Disease (LEOPARD) - a multinational team initiativeMarcel Grube, Bianca Ribeiro de Souza, Andrea Neilson, et al.
British Journal of Cancer|November 3, 2022
Increased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium StudyAshley Weir, Eun-Young Kang, Nicola S Meagher, et al.
Pageof 13